Key takeaways
- This segment features Kevin Kelly, President and CEO of Resonetics, speaking from the company’s booth at MD&M West in Anaheim about the company’s mission to help partners bring life-changing devices to market.
- Resonetics, a leading Contract Development and Manufacturing Organization (CDMO), continues to expand its core capabilities, spanning nitinol and laser processing, component processing, Swiss screw machining, and semi-finished materials (wire, sheet, tubing), alongside newer additions in sensors and battery products.
- The company’s end-to-end model pairs its Lightspeed Labs team (rapid prototyping and process development) with its AGILE Product Development group (engineering and manufacturing support across all development phases) to compress customer timelines from prototype to finished device.
- Over the past six months, Resonetics has made two acquisitions to broaden its offering: Resolution Medical (agreed in January), expanding end-to-end capabilities in neuromodulation, structural heart, and interventional cardiology; and Eden Holdings (acquired in September), adding injection molding and micro machining expertise.
- Customer- and patient-centricity is a core company value at Resonetics, tying business growth directly to better patient outcomes, and points viewers to the company’s newly relaunched website.
